GL1X · GenesisL1 explorer

Research workbench

Crystal structure of ZAK in complex with compound 6k

Analyse Crystal structure of ZAK in complex with compound 6k in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6JUT
Type
protein
Length
297 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.1
Source
Homo sapiens
Molecule
Mitogen-activated protein kinase kinase kinase MLT
EC
2.7.11.25
UniProt
Q9NYL2
Ligands
C9O
Pockets
2 · best druggability 0.76

Structure

x-ray diffraction · resolution 2.1 · 1 distinct chain · 47% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase kinase kinase MLT (EC 2.7.11.25)protein29747% helix, 15% strandQ9NYL2

Ligands and binding sites

  • C9O · ~{N}-[2,4-bis(fluoranyl)-3-[4-(3-methoxy-1~{H}-pyrazolo[3,4-b]pyridin-5-yl)-1,2,3-triazol-1-yl]phenyl]-3-bromanyl-benzenesulfonamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16700.760.8164C9O
2500.300.7620empty

Compared structures

  • 6JUT · Crystal structure of zak in complex with compound 6K · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9NYL2 · AlphaFold monomer V2.0 prediction for mitogen-activated protein kinase kinase kinase 20… · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.